CRISPR–Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames
Caishang Zheng(The University of Texas MD Anderson Cancer Center), Yiwen Chen(The University of Texas MD Anderson Cancer Center), Anna Malovannaya(Baylor College of Medicine), Antrix Jain(Baylor College of Medicine), Ximing Tang(The University of Texas MD Anderson Cancer Center), Kangyu Lin(The University of Texas MD Anderson Cancer Center), Yarui Diao(Duke University), Shaolong Cao(The University of Texas MD Anderson Cancer Center), Yanjun Wei(Harbin Medical University), Hongqi Teng(The University of Texas MD Anderson Cancer Center), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Sherita Meyer-Gauen(The University of Texas MD Anderson Cancer Center), Wen Liu(Xinjiang Medical University), Wenbo Li(The University of Texas MD Anderson Cancer Center), Wenyi Wang(The University of Texas MD Anderson Cancer Center), Peng Zhang, Zhao Zhang(Jilin Jianzhu University), Nelufa Islam(Baylor College of Medicine), Han Xu(The University of Texas MD Anderson Cancer Center), Wei He(The University of Texas MD Anderson Cancer Center), Magnus Höök(Texas Medical Center), Yulun Chiu(Institute of Bioinformatics), Ming Hu(Shihezi University), Dandan He(Guiyang Medical University), Scott Kopetz(The University of Texas MD Anderson Cancer Center)
Cited by 25
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k